Identification of immune biomarkers in recent active pulmonary tuberculosis

Author:

Shaukat Sobia Naz,Eugenin Eliseo,Nasir Faizan,Khanani Rafiq,Kazmi Shahana Urooj

Abstract

AbstractTuberculosis (TB) has remained an unsolved problem and a major public health issue, particularly in developing countries. Pakistan is one of the countries with the highest tuberculosis infection rates globally. However, methods or biomarkers to detect early signs of TB infection are limited. Here, we characterized the mRNA profiles of immune responses in unstimulated Peripheral blood mononuclear cellsobtained from treatment naïve patients with early signs of active pulmonary tuberculosis without previous history of clinical TB. We identified a unique mRNA profile in active TB compared to uninfected controls, including cytokines such as IL-27, IL-15, IL-2RA, IL-24, and TGFβ, transcription factors such as STAT1 and NFATC1 and immune markers/receptors such as TLR4, IRF1, CD80, CD28, and PTGDR2 from an overall 84 different transcripts analyzed. Among 12 significant differentially expressed transcripts, we identified five gene signatures which included three upregulated IL-27, STAT1, TLR4 and two downregulated IL-24 and CD80 that best discriminate between active pulmonary TB and uninfected controls with AUC ranging from 0.9 to 1. Our data identified a molecular immune signature associated with the early stages of active pulmonary tuberculosis and it could be further investigated as a potential biomarker of pulmonary TB.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference71 articles.

1. Pai, M. et al. Nature reviews disease primers. Tuberculosis 2, 16076 (2016).

2. Virenfeldt, J. et al. Treatment delay affects clinical severity of tuberculosis: A longitudinal cohort study. BMJ Open 4, e004818 (2014).

3. World Health Organization. Tuberculosis, Key facts, https://www.who.int/news-room/fact-sheets/detail/tuberculosis (2021).

4. Ross, J. M. et al. Estimating the population at high risk for tuberculosis through household exposure in high-incidence countries: A model-based analysis. EClinicalMedicine 42, 101206 (2021).

5. The World Bank. Incidence of Tuberculosis, https://data.worldbank.org/indicator/SH.TBS.INCD (2020–2021).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3